BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9195274)

  • 1. Mutational and susceptibility genetics are different clinical paradigms.
    Roses AD
    Int Psychogeriatr; 1997 Mar; 9(1):7-10. PubMed ID: 9195274
    [No Abstract]   [Full Text] [Related]  

  • 2. Alzheimer's disease: the genetics of risk.
    Roses AD
    Hosp Pract (1995); 1997 Jul; 32(7):51-5, 58-63, 67-9. PubMed ID: 9227658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of association between NOS3 poly morphism and Italian sporadic and familial Alzheimer's disease.
    Tedde A; Nacmias B; Cellini E; Bagnoli S; Sorbi S
    J Neurol; 2002 Jan; 249(1):110-1. PubMed ID: 11954859
    [No Abstract]   [Full Text] [Related]  

  • 4. Survival in Finnish centenarians in relation to apolipoprotein E polymorphism.
    Louhija J; Viitanen M; Agüero-Torres H; Tilvis R
    J Am Geriatr Soc; 2001 Jul; 49(7):1007-8. PubMed ID: 11527502
    [No Abstract]   [Full Text] [Related]  

  • 5. [Genetics of Alzheimer's disease].
    Hiltunen M; Helisalmi S; Kivipelto M; Soininen H
    Duodecim; 2004; 120(20):2425-31. PubMed ID: 15641511
    [No Abstract]   [Full Text] [Related]  

  • 6. Psychiatric genetics: what to expect.
    Hallmayer JF
    Curr Psychiatry Rep; 2004 Jun; 6(3):149-50. PubMed ID: 15142466
    [No Abstract]   [Full Text] [Related]  

  • 7. Haplogroup analysis of the risk associated with APOE promoter polymorphisms (-219T/G, -491A/T and -427T/C) in Colombian Alzheimer's disease patients.
    Parra-Bonilla G; Arboleda G; Yunis J; Solano E; Pardo R; Arango G; Hedmont D; Arboleda H
    Neurosci Lett; 2003 Oct; 349(3):159-62. PubMed ID: 12951193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of APOE genotype on clinical phenotype in Alzheimer disease.
    Borroni B; Di Luca M; Padovani A
    Neurology; 2007 Feb; 68(8):624; author reply 624. PubMed ID: 17310043
    [No Abstract]   [Full Text] [Related]  

  • 9. Susceptibility genetics in the etiopathogenesis of Alzheimer's disease: role for potential confounding factors.
    Harrington CR; Roth M
    Int Psychogeriatr; 1997 Sep; 9(3):229-44. PubMed ID: 9513025
    [No Abstract]   [Full Text] [Related]  

  • 10. Lack of association of the interleukin-1alpha gene polymorphism with Alzheimer's disease in a Korean population.
    Ki CS; Na DL; Kim DK; Kim HJ; Kim JW
    Ann Neurol; 2001 Jun; 49(6):817-8. PubMed ID: 11409441
    [No Abstract]   [Full Text] [Related]  

  • 11. Genetic association of an apolipoprotein C-I (APOC1) gene polymorphism with late-onset Alzheimer's disease.
    Ki CS; Na DL; Kim DK; Kim HJ; Kim JW
    Neurosci Lett; 2002 Feb; 319(2):75-8. PubMed ID: 11825674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of vascular risk to the progression of Alzheimer disease.
    Borroni B; Archetti S; Ferrari M; Cesana BM; Padovani A
    Neurology; 2007 Mar; 68(13):1083-4; author reply 1084. PubMed ID: 17389321
    [No Abstract]   [Full Text] [Related]  

  • 13. Gene polymorphisms of interleukin-1alpha influence the course of Alzheimer's disease.
    Kölsch H; Ptok U; Bagli M; Papassotiropoulos A; Schmitz S; Barkow K; Kockler M; Rao ML; Maier W; Heun R
    Ann Neurol; 2001 Jun; 49(6):818-9. PubMed ID: 11409442
    [No Abstract]   [Full Text] [Related]  

  • 14. A genetic dichotomy model for the inheritance of Alzheimer's disease and common age-related disorders.
    Tanzi RE
    J Clin Invest; 1999 Nov; 104(9):1175-9. PubMed ID: 10545516
    [No Abstract]   [Full Text] [Related]  

  • 15. No association of the -48CT polymorphism of the presenilin 1 gene with Alzheimer disease in a late-onset sporadic population.
    Araria-Goumidi L; Huguet JB; Lambert JC; Frigard B; Cottel D; Amouyel P; Chartier-Harlin MC
    J Neural Transm (Vienna); 2002 Jul; 109(7-8):1023-7. PubMed ID: 12111439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic association of alpha2-Heremans-Schmid glycoprotein polymorphism with late-onset Alzheimer's disease in Italians.
    Geroldi D; Minoretti P; Bianchi M; Di Vito C; Reino M; Bertona M; Emanuele E
    Neurosci Lett; 2005 Oct; 386(3):176-8. PubMed ID: 16002217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of BDNF Val66Met functional polymorphism in Alzheimer's disease-related depression.
    Borroni B; Archetti S; Costanzi C; Grassi M; Ferrari M; Radeghieri A; Caimi L; Caltagirone C; Di Luca M; Padovani A;
    Neurobiol Aging; 2009 Sep; 30(9):1406-12. PubMed ID: 18179845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The microtubule associated protein Tau gene and Alzheimer's disease--an association study and meta-analysis.
    Russ C; Powell JF; Zhao J; Baker M; Hutton M; Crawford F; Mullan M; Roks G; Cruts M; Lovestone S
    Neurosci Lett; 2001 Nov; 314(1-2):92-6. PubMed ID: 11698154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association analysis of brain-derived neurotrophic factor (BDNF) gene 196 A/G polymorphism with Alzheimer's disease (AD) in mainland Chinese.
    Bian JT; Zhang JW; Zhang ZX; Zhao HL
    Neurosci Lett; 2005 Oct; 387(1):11-6. PubMed ID: 16054753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of association between Alzheimer disease and the -491 regulatory region polymorphism of APOE.
    Song YQ; Rogaeva E; Premkumar S; Brindle N; Kawarai T; Orlacchio A; Yu G; Levesque G; Nishimura M; Ikeda M; Pei Y; O'Toole C; Duara R; Barker W; Sorbi S; Freedman M; Farrer L; St George-Hyslop P
    Neurosci Lett; 1998 Jul; 250(3):189-92. PubMed ID: 9708864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.